Fennec Pharmaceuticals Inc.
HealthcareNASDAQ:FENC · NASDAQ Capital Market
+$0.15 today
Vol 0.25M · Avg 0.26M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+13.49%
Period High
$9.98
Period Low
$5.77
Latest
$9.00
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$352.45M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$284.66M
Cartesian Therapeutics, Inc.
NASDAQ:RNAC
$279.42M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$276.28M
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
$245.51M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$202.22M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$166.70M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$158.19M
Black Diamond Therapeutics, Inc.
NASDAQ:BDTX
$100.28M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$85.08M
What is the latest FENC filing?
The latest filing shown is S-8 dated Jun 11, 2026.
How many recent filings does FENC have?
Intrinsic Alpha currently shows 20 recent filings for FENC.
Explore More
Continue the stock analysis
Jump to another research area for this company.